Articles From: MasterCard + McCann Win The 2014 Grand Midas Award For Global Creative Excellence In Financial Marketing to Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative


2014/12/4
MCCANN WORLDGROUP WINS TOTAL OF 10 GOLDS FOR 4 FINANCIAL CLIENTS AROUND THE WORLD NEW YORK , Dec.
Sign-up for MasterCard + McCann Win The 2014 Grand Midas Award For Global Creative Excellence In Financial Marketing investment picks
2014/12/4
Common Core State Standards, education reform and growth mindset among top themes for keynote address DALLAS , Dec.
Sign-up for Mathematics reform champion Jo Boaler to deliver keynote speech at Texas Instruments' Teachers Teaching with Technology™ Conference investment picks
Mavenir Systems® (NYSE:MVNR), a leading provider of software-based networking solutions, and T-Mobile Czech Republic announce the successful joint deployment of a converged IMS Core and Voice over LTE (VoLTE) Application Server solution and the successful first VoLTE call and limited pilot in their live network.
Sign-up for Mavenir’s IMS Core and VoLTE Solution Deployed at T-Mobile Czech Republic investment picks
2014/12/4
McCoy Global Inc. announces quarterly dividend Canada NewsWire EDMONTON , Dec.
Sign-up for McCoy Global Inc. announces quarterly dividend investment picks
ARLINGTON, Va., Dec.
Sign-up for MCG Capital Announces Preliminary Results of Its Tender Offer investment picks
Mead Johnson Nutrition Company (NYSE: MJN) announced today that its board of directors has declared a regular quarterly common stock dividend of $0.375 per share for the quarter ending December 31, 2014.
Sign-up for Mead Johnson Board of Directors Declares Dividend investment picks
2014/12/4
Media Advisory - Transat A.T. Inc. - Results of Fourth Quarter and Fiscal Year 2014 Canada NewsWire MONTREAL , Dec.
Sign-up for Media Advisory - Transat A.T. Inc. - Results of Fourth Quarter and Fiscal Year 2014 investment picks
The vast majority of corporate sales representatives are consistently average performers but could boost the competitiveness of companies by generating hundreds of millions of dollars in additional revenue each year for those businesses able to lift their performance even modestly, according to new research from Accenture (NYSE: ACN) and CSO Insights.
Sign-up for Mediocre Performance by a Majority of Sales Representatives Cost Companies 3.2 Percent in Potential Revenue, Accenture Research Shows investment picks
2014/12/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982727001&sourceType=1 http://media3.marketwire.com/logos/20121210-meg1210.jpg CALGARY, ALBERTA --
Sign-up for MEG Energy announces $1.2 billion 2015 capital budget investment picks
MEGA® Brands "must-have" holiday toys win notable awards - Mega Bloks® and RoseArt® offer something special for every member of the family Canada NewsWire MONTREAL , Dec.
Sign-up for MEGA® Brands "must-have" holiday toys win notable awards - Mega Bloks® and RoseArt® offer something special for every member of the family investment picks
2014/12/4
LONDON-- Barclays PLC (BARC.LN) Thursday said members of the management team at the theme park operator Merlin Entertainments PLC (MERL.LN) have sold shares worth 31.7 million pounds ($49.7 million) in a placing.
Sign-up for Merlin Entertainments Management Sells Shares Worth GBP31.7 Million investment picks
Innovative DC-powered PoE Midspans Designed for Small Cells, IP Applications, Security and other High-powered Solutions; Wins in the Exceptional Technical Innovation Category ALISO VIEJO, Calif.
Sign-up for Microsemi DC-powered PoE Midspans Win the Renewable Energy Design Award at the Elektra European Electronics Industry Awards 2014 investment picks
Microsoft Corp.
Sign-up for Microsoft shares rise as Nomura lifts price target investment picks
By Rex Crum, MarketWatch Software giant gets lift as Nomura analyst raises price target SAN FRANCISCO (MarketWatch) -- Tech bellwethers Microsoft Corp.
Sign-up for Microsoft's a rare tech gainer in mixed session investment picks
http://media.marketwire.com/attachments/201310/199498_MidcoastEnergyPartners_Stack_rgb.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163200&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for Midcoast Energy Partners, L.P. Announces Business Outlook and 2015 Financial Guidance investment picks
Millennial Media (NYSE:MM), the leading independent mobile marketplace, today announced the acquisition of mobile supply-side platform (SSP) and programmatic pioneer Nexage.
Sign-up for Millennial Media Completes Acquisition of Nexage to Create the Leading Independent Mobile Marketplace investment picks
2014/12/4
MobileSmith announced the release of a Private Cloud Appliance , which the company refers to as MobileSmith Pod.
Sign-up for MobileSmith Delivers Private Cloud Appliance to Facilitate Integration of Client Apps with Data investment picks
2014/12/4
BUDAPEST--Hungarian oil and gas company MOL Nyrt.
Sign-up for MOL Settles, Re-Enters Share Option Pact with Credit Agricole investment picks
2014/12/4
DEERFIELD, Ill.
Sign-up for Mondelez International Declares Regular Quarterly Dividend of $0.15 Per Share investment picks
MADD partnership in the national car donation campaign generates funding and helps raise public awareness about the benefits of donating a vehicle WESTCHESTER, Ill.
Sign-up for Mothers Against Drunk Driving (MADD) Becomes Benefactor Partner of IAA's One Car One Difference® Car Donation Program investment picks
Enhances E-commerce Expertise NEW YORK , Dec.
Sign-up for MRM//McCann Expands E-commerce Footprint With Acquisition Of Optaros, Inc. investment picks
2014/12/4
MyECheck, Inc. (OTC PK: MYEC), the leader in electronic check solutions for internet and mobile payments, has named Jim Fancher as executive vice president.
Sign-up for MyECheck Appoints Jim Fancher as Executive Vice President investment picks
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative Canada NewsWire LONDON and PITTSBURGH , Dec.
Sign-up for Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: MasterCard + McCann Win The 2014 Grand Midas Award For Global Creative Excellence In Financial Marketing to Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent